OAG 027 – July 2020 Related Content

Here, Rob Fotheringham, Director of Fotheringham Associates, explains how pseudonymisation can allow organisations to utilise invaluable data received through the emergency response to COVID-19, to benefit future research and analysis.

A group of experts from the World Health Organization explain the Global Influenza Strategy for 2019-2030 that charts the path towards greater global influenza prevention, control, and preparedness through 2030.

Stephen Simpson, Director of Research at Versus Arthritis, charts arthritis and related conditions, the biggest causes of pain in the UK today.

Philippe JACQUES, Managing Director of EMIRI, explores how advanced materials can be used to solve global challenges such as the current COVID-19 pandemic.

There has been a paradigm shift in the workplace, and here, Bob Hallewell explains how to approach New Order working.

Here, the International Agency for Research on Cancer and other experts provide an in-depth analysis of cancer, the second leading cause of death after cardiovascular diseases plus the role of technology and innovation in the field.

Stuart Snape, Managing Partner, Graham Coffey & Co. Solicitors, walks us through what the COVID-19 pandemic has taught us about the need for urgent sepsis care.

Aarthi Janakiraman, Research Manager, Chemicals and Advanced Materials at TechVision, Frost & Sullivan, explores if nanotechnology aids the battle against COVID-19.

Richard Blanford, Chief Executive of Fordway, discusses how technology procurement frameworks help organisations speed up purchasing and obtain better value services.

Prashant Dogra1, Kavya Sinha2, Zhihui Wang1, Vittorio Cristini1,* 1Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, Texas 2Department of Cardiovascular Surgery, Houston Methodist DeBakey Heart & Vascular Center, Houston, Texas *Correspondence: vcristini@houstonmethodist.org Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a pathogen of immense public health concern, having caused ~4.1 million confirmed...

Here, Megan Warrender looks into the strides being made by the NIDCR to support dental research and innovation, and, in particular, how current initiatives feed into long term plans for dental, oral and craniofacial health and disease in the U.S.

Here, we discover that the EFFECT4buildings project provides a set of financial tools and instruments for lowering the risks of energy efficiency investments.

Debbie McGill, Head of Policy and Public Affairs at the Association of British Dispensing Opticians, tells us all we need to know on accessing eye care and the leading causes of sight loss in the UK.

Dr Larisa Corda, leading Obstetrician and Gynaecologist sheds some light on how vitamin D supplementation canbe vital to maintaining good health during pregnancy, particularly throughout the COVID-19 pandemic.

Here, R.M Winglee and M. Danner, Department of Earth and Space Sciences, University of Washington, discuss robotic exploration and High-Velocity Impactors.

Funding for government building projects may seem like a low priority now, but looking ahead, ensuring these buildings work smarter will be key to restoring normal business operations, argues Liz Farrimond from iDAC Solutions Ltd.

Ross Linnett, Founder and CEO of Recite Me, explains how public sector bodies can write a top web accessibility statement to comply with the looming deadline imposed by the UK’s new web accessibility laws.

John Binns, Partner at BCL Solicitors LLP, provides us with fresh insight into COVID-19 and medical cannabis. He ponders if the crisis could bring opportunities for the industry.

The Division of Chemistry at the National Science Foundation, provides an update on their work in driving discovery and development concerning chemistry research that improves the quality of life in the United States.

In this energy consumption in buildings focus, the implementation of a district heating project in a residential area is described in detail by Erik Christiansen, CEO of EBO Consult A/S.